AFFINITY ASSET ADVISORS, LLC
AFFINITY ASSET ADVISORS, LLC runs AFFINITY ASSET ADVISORS, LLC and currently holds 113 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $2.21B. Their top holdings are ROIV, APGE, SYRE, XENE, ERAS. The top five represent 25.8% of reported portfolio weight. AFFINITY ASSET ADVISORS, LLC ranks #113 out of 1000 investors tracked by Alpha Score. In the most recent quarter, AFFINITY ASSET ADVISORS, LLC initiated 4 new positions. They added to 13 existing positions. They trimmed 18 positions. Their current best-performing preview position is CMPS with returns of +155.88%.
113 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
ROIV ROIVANT SCIENCES LTD | 6.00% | $25.07 | $36.30 | +44.79% | Added +33.93% |
APGE APOGEE THERAPEUTICS INC | 5.92% | $40.36 | $134.75 | +233.87% | Trimmed -23.19% |
SYRE SPYRE THERAPEUTICS INC | 5.13% | $18.01 | $106.49 | +491.28% | Held |
XENE XENON PHARMACEUTICALS INC | 4.35% | $44.05 | $60.77 | +37.96% | Trimmed -4.78% |
ERAS ERASCA INC | 4.35% | $5.85 | $17.63 | +201.37% | Trimmed -1.87% |
INSM INSMED INC | 3.13% | $99.41 | $125.77 | +26.52% | Added +35.42% |
PRAX PRAXIS PRECISION MEDICINES I | 2.80% | $297.99 | $375.94 | +26.16% | Added +8.82% |
ALKS ALKERMES PLC | 2.66% | $29.12 | $48.33 | +65.97% | Trimmed -16.67% |
ORKA ORUKA THERAPEUTICS INC | 2.54% | $30.68 | $107.96 | +251.89% | Added +18.08% |
ANAB ANAPTYSBIO INC | 2.52% | $34.77 | $57.74 | +66.06% | Trimmed -12.12% |
Showing 1-10 of 113